Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
26.7%
% of FBT's 31 holdings also in CANC
17.0%
% of CANC's 47 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
GENMAB A/S SPONSORED ADR | 3.8% | 4.0% | 3.8% |
 |
EXELIXIS INC | 3.7% | 4.0% | 3.7% |
|
AMGEN INC | 3.2% | 3.4% | 3.2% |
|
BEIGENE LTD. SPONSORED ADR | 3.6% | 2.8% | 2.8% |
 |
ARGENX SE ADR | 3.1% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to CANC
|
ACADIA PHARMACEUTICALS INC | 4.6% |
|
NEUROCRINE BIOSCIENCES INC | 4.2% |
|
ALNYLAM PHARMACEUTICALS INC | 4.0% |
|
EXACT SCIENCES CORP | 3.7% |
|
INCYTE CORP | 3.7% |
|
BIOGEN IDEC INC | 3.5% |
|
NATERA INC | 3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.4% |
 |
ALKERMES PLC | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
FBT Underweight Relative to CANC
|
ELI LILLY & CO | -5.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -5.2% |
|
REVOLUTION MEDICINES, INC. | -5.2% |
|
NOVARTIS AG | -4.3% |
 |
ASTRAZENECA PLC | -4.2% |
|
BRIDGEBIO PHARMA, INC. | -4.2% |
 |
MERUS N.V. | -3.8% |
|
BRISTOL-MYERS SQUIBB CO | -3.6% |
|
NUVALENT, INC. CLASS A | -3.4% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.3% |